Morgan Stanley’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16
Closed -$246 8197
2025
Q2
$246 Hold
16
﹤0.01% 7544
2025
Q1
$271 Sell
16
-1
-6% -$20 ﹤0.01% 7438
2024
Q4
$418 Hold
17
﹤0.01% 7361
2024
Q3
$898 Buy
+17
New +$910 ﹤0.01% 7234
2024
Q1
Sell
-42
Closed -$2.14K 7842
2023
Q4
$2.14K Buy
+42
New +$2.06K ﹤0.01% 7131
2023
Q2
Sell
-144
Closed -$7.25K 7663
2023
Q1
$7.25K Hold
144
﹤0.01% 6970
2022
Q4
$8.77K Buy
144
+121
+526% +$9.34K ﹤0.01% 6985
2022
Q3
$2K Hold
23
﹤0.01% 7452
2022
Q2
$2K Sell
23
-20
-47% -$2.17K ﹤0.01% 7574
2022
Q1
$6K Buy
43
+20
+87% +$2.97K ﹤0.01% 7532
2021
Q4
$4K Sell
23
-6
-21% -$1.21K ﹤0.01% 7679
2021
Q3
$7K Hold
29
﹤0.01% 7416
2021
Q2
$9K Hold
29
﹤0.01% 7261
2021
Q1
$10K Buy
+29
New +$9.79K ﹤0.01% 6932

Other funds holding CNBS

Morgan Stanley's CNBS Position: Q3 2025 in Review

Morgan Stanley sold out of Amplify Seymour Cannabis ETF (CNBS) in Q3 2025, closing a stake of 16 shares — an estimated $246 sold.

Morgan Stanley first reported a position in CNBS in Q1 2021 and held it in 14 quarters. The position peaked at $10K in Q1 2021. 20 funds tracked by Wall St. Rank hold CNBS as of Q3 2025.

  • Morgan Stanley reported no remaining Amplify Seymour Cannabis ETF position as of Q3 2025 after selling out during the quarter.
  • Morgan Stanley sold 16 Amplify Seymour Cannabis ETF shares in Q3 2025, an estimated $246.
  • Morgan Stanley first reported a position in Amplify Seymour Cannabis ETF in Q1 2021 and held it in 14 quarters.
  • Morgan Stanley's Amplify Seymour Cannabis ETF position peaked at $10K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q3 2025.

Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.